beyond heartbreak (JMSP USA LLC)
Welcome to the PulseAid listing for the beyond heartbreak drug offered from JMSP USA LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | JMSP USA LLC |
NON-PROPRIETARY NAME: | Ignatia, Natrum Muriaticum , Pulsatilla,Staphysagria |
SUBSTANCE NAME: | STRYCHNOS IGNATII SEED; SODIUM CHLORIDE; ANEMONE PULSATILLA; DELPHINIUM STAPHISAGRIA SEED |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | SPRAY |
MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
START MARKETING DATE: | 2017-06-10 |
END MARKETING DATE: | 0000-00-00 |
beyond heartbreak HUMAN OTC DRUG Details:
Item Description | beyond heartbreak from JMSP USA LLC |
LABELER NAME: | JMSP USA LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 30; 30; 30; 30([hp_C]/30mL; 1/30mL; 1/30mL; 1/30mL) |
START MARKETING DATE: | 2017-06-10 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 58214-123_6d3701dc-cffc-4cce-8e55-77ebce864dfb |
PRODUCT NDC: | 58214-123 |
APPLICATION NUMBER: | |
Other STRYCHNOS IGNATII SEED; SODIUM CHLORIDE; ANEMONE PULSATILLA; DELPHINIUM STAPHISAGRIA SEED Pharmaceutical Manufacturers / Labelers: